Measuring online endorsement of prescription opioids abuse: An integrative methodology

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 10, 2012, Pages 1081-1092

  Mcnaughton, Emily C ^a   Black, Ryan A ^a   Zulueta, Mirella G ^a   Budman, Simon H ^a   Butler, Stephen F ^a  

^a INFLEXXION INC   (United States)

Author keywords

Content analysis; Endorsement; Internet monitoring; Opioids; Pharmacoepidemiology; Prescription drug abuse; Surveillance

Indexed keywords

HYDROCODONE; HYDROMORPHONE; MORPHINE; OXYCODONE; OXYMORPHONE; TRAMADOL;

ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG SURVEILLANCE PROGRAM; ELECTRONIC PRESCRIBING; HUMAN; INTERNET; METRIC SYSTEM; ONLINE SYSTEM; OPIATE ADDICTION; PATIENT PREFERENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SELF REPORT;

ANALGESICS, OPIOID; DRUG MONITORING; DRUG USERS; HUMANS; ONLINE SYSTEMS; PRESCRIPTION DRUGS;

EID: 84867139957     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3307     Document Type: Article

References (43)

1. Office of National Drug Control Policy (ONDCP). April 2011. Available at http://www.whitehousedrugpolicy.gov/publications/pdf/rx_abuse_plan.pdf; http://www.whitehousedrugpolicy.gov/mobile/041911.html; http://www.whitehousedrugpolicy.gov/drugfact/nsduh.html
2. Arfken CL, Cicero TJ. Postmarketing surveillance for drug abuse. Drug Alcohol Depend 2003; 70: S97-S105.
3. GAO US General Accounting Office. 2003. Prescription drugs: OxyContin abuse and diversion and efforts to address the problem. OxyContin Abuse and Diversion Report to Congressional Requesters (GAO-04-110). Available online at http://www.gpoaccess.gov/gaoreports/index.html
4. Volkow ND. Message from the Director: Increased abuse of prescription drugs is cause for concern. 2004. Available online from NIDA at http://www.drugabuse.gov/about/welcome/message304.html
5. Compton WM, Volkow N. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend 2006; 81: 103-107.
6. SDI, Vector One: National. Years 2000-2009. Available at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupport DrugsAdvisoryCommittee/UCM217510.pdf
7. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: National Findings (Office of Applied Studies). NSDUH Series H-38A, HHS Publication No. SMA 10-4586Findings. 2010; Rockville, MD.
8. Inciardi JA, Surratt HL, Cicero TJ, Kurtz SP, Martin SS, Parrino MW. The "black box" of prescription drug diversion. J Addict Dis 2009; 28(4): 332-347.
9. Cicero TJ, Kurtz SP, Surratt HL, Ibanez GE, Ellis MS, Levi-Minzi MA, Inciardi JA. Multiple Determinants of Specific Modes of Prescription Opioid Diversion. J Drug Issues 2011 Spring; 41(2): 283-304.
10. Manchikanti L, Fellow B, Ailinani H, Pampati V. Therapeutic Use, Abuse, and Nonmedical Use of Opioids: A Ten- Year Perspective. Pain Physician 2010; 13: 401-435.
11. Strassels SA. Economic Burden of Prescription Opioid Misuse and Abuse. J Manag Care Pharm 2009; 15(7): 556-562.
12. FDA. Questions and Answers: FDA Requires a Risk Evaluation and Mitigation Strategy (REMS) for Long-Acting and Extended-Release Opioids. Rockville; April 2011. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm251752.htm
13. Castillo-Salgado C. The rapid expansion of health information technologies and the internet. Epidemiol Rev 2009; 32(1): 93-109.
14. Schifano F, Deluca P, Baldacchino A, et al. Drugs on the web; the Psychonaut 2002 EU project. Prog Neuropsychopharmacology Biol Psychiatry 2006; 30(4): 640-646.
15. Mounteney J, Leirvag SE. Providing an earlier warning of emerging drug trends: the Fare Var System. Drugs Educ Prev Pol 2004; 11: 449-471.
16. Gordon S, Forman RF, Siatkowski C. Knowledge and use of the internet as a source of controlled substances. J Subst Abuse Treat 2006; 30(3): 271-274.
17. Boyer EW, Lapen PT, Macalino G, Hibberd PL. Dissemination of psychoactive substance information by innovative drug users. Cyberpsychol Behav 2007; 10(1): 1-6.
18. Wax PM. Just a click away: recreational drug websites on the Internet. Pediatrics 2002; 109: 1-48.
19. Zinkham GM, Kwak H, Morrison M, et al. Web-based chatting: consumer communication in cyberspace. J Consum Psychol 2003; 13: 17-27.
20. Nielsen S, Barratt MJ. Prescription drug misuse: is technology friend or foe? Drug Alcohol Rev 2009; 28(1): 81-86.
21. Abratt R, Nel D, Nezer C. Role of the market maven in retailing: A general marketplace influencer. Journal of Business and Psychology 1995: 10: 31-56.
22. Walsh G, Mitchell VW, Weidmann KP, Frenzel T, Duvenhorst C. German eMavens on Internet music sites. In Proceedings: Enhancing knowledge development in marketing. AMA 2002 Summer Educators' Conference. Vol 13, WJ Kehoe, & JH Lindgren (eds.). American Marketing Association: Chicago, IL, pp. 435-436.
23. Walsh G, Gwinner KP, Swanson SR. What makes mavens tick? Exploring motives of market mavens' initiation of information diffusion. J Consumer Marketing 2004; 21: 109-122.
24. Bei L-T, Chen EYI, Widdows R. Consumers' online information search behavior and the phenomenon of search vs Experience products. J Family & Economic Issues 2004; 25(4): 449-467.
25. Nonnecke B, Preece J. Lurker demographics: Counting the silent. Proceedings of CHI. ACM: The Hague, 2000.
26. Rogers E. Diffusion of Innovations. Free Press: New York, 1995.
27. Gladwell M The Tipping Point. Abacus: New York, 2000.
28. Murgia E. Real drugs in a virtual world: drug discourse and community online. Lexington Books: New York, 2007.
29. Li N, Wu DD. Using text mining and sentiment analysis for online forums hotspot detection and forecast. Decision Support Systems 2010; 48(2): 354-368.
30. Guibourgé J, Bonny P. Internet emotional discourse analysis and innovation - a mix semiotic and text-mining method. 2010. Available at http://www.inevidence.com/fr/docs/Internet_emotional_discourse_analysis-DPPI09.pdf
31. Cerrito P. Sentiment mining using SAS® text miner®. SAS Global Forum 2011; Paper 161.
32. Vadivelu N, Timchenko A, Huang Y, and Sinatra R. Tapentadol extended-release for treatment of chronic pain: a review. J Pain Research 2011; 4: 211-218.
33. Butler SF, Katz N, Venuti S, Benoit C, Beaulaurier RL. Content analysis and monitoring of internet prescription opioid abuse-related postings. J Pain 2006; 7(4): Supplement 1: S86.
34. Butler SF, Venuti SW, Benoit C, Beaulaurier RL, Houle B, Katz N. Internet surveillance: content analysis and monitoring of product-specific internet prescription opioid abuse-related postings. Clin J Pain 2007; 23(7): 619-628.
35. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
36. Kuss O, McLerran D. A note on the estimation of the multinomial logistic model with correlated responses in SAS. Comput Methods Programs Biomed 2007; 262-269.
37. Butler SF, Benoit C, Budman SH, Fernandez KC, McCormick C, Venuti SW, Katz N. Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm Reduct J. 2006; 3: 5.
38. Butler SF, Fernandez KC, Chang A, Benoit C, Morey LC, Black R, Katz N. Measuring attractiveness for abuse of prescription opioids. Pain Med 2010; 11(1): 67-80. Epub 2009 Nov 25.
39. Butler SF, Black R, Grimes Serrano JM, Folensbee L, Chang A, Katz N. Estimating attractiveness for abuse of a not-yet-marketed "abuse-deterrent" prescription opioid formulation. Pain Med 2010; 11(1): 81-91. Epub 2009 Nov 25.
40. Butler SF, Black RA, Cassidy TA, Dailey TM, Budman SH. Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduct J 2011; 8: 29.
41. Dasgupta N, Kramer ED, Zalman MA, et al. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend 2006; 82: 135-142.
42. Kendall MG, Babington-Smith B. The Problem of m Rankings. The Annals of Mathematical Statistics 1939; 10(3): 275-287.
43. Siegel S, Castellan Jr NJ. Nonparametric Statistics for the Behavioral Sciences, (2nd ed.). McGraw-Hill: New York, 1988; p. 266.